Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127387841 | 12738784 | 1 | I | 20160901 | 20160912 | 20160912 | EXP | GB-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000317 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160912 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127387841 | 12738784 | 1 | PS | perindopril | PERINDOPRIL | 1 | Oral | 6 MG, QD | Y | U | UNKNOWN | 20184 | 6 | MG | TABLET | ||||
127387841 | 12738784 | 2 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 2.5 MG, QD | Y | U | UNKNOWN | 0 | 2.5 | MG | TABLET | ||||
127387841 | 12738784 | 3 | C | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | 20 MG, QD | U | UNKNOWN | 0 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127387841 | 12738784 | 1 | Hypertension |
127387841 | 12738784 | 2 | Hypertension |
127387841 | 12738784 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127387841 | 12738784 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127387841 | 12738784 | Asthenia | |
127387841 | 12738784 | Dizziness | |
127387841 | 12738784 | Dysarthria | |
127387841 | 12738784 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |